MX363826B - Composicion farmaceutica a base de centella asiatica (hydrocotyle asiatica l.) para el tratamiento de ulceras en miembros inferiores. - Google Patents

Composicion farmaceutica a base de centella asiatica (hydrocotyle asiatica l.) para el tratamiento de ulceras en miembros inferiores.

Info

Publication number
MX363826B
MX363826B MX2013004077A MX2013004077A MX363826B MX 363826 B MX363826 B MX 363826B MX 2013004077 A MX2013004077 A MX 2013004077A MX 2013004077 A MX2013004077 A MX 2013004077A MX 363826 B MX363826 B MX 363826B
Authority
MX
Mexico
Prior art keywords
asiatica
pharmaceutical composition
ulcers
composition based
hydrocotyle
Prior art date
Application number
MX2013004077A
Other languages
English (en)
Other versions
MX2013004077A (es
Inventor
Lucía Montañez Soto Flor
Original Assignee
Flor Lucia Montanez Soto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flor Lucia Montanez Soto filed Critical Flor Lucia Montanez Soto
Priority to MX2013004077A priority Critical patent/MX363826B/es
Priority to PCT/IB2014/000510 priority patent/WO2014167405A1/en
Priority to US14/784,085 priority patent/US10232004B2/en
Publication of MX2013004077A publication Critical patent/MX2013004077A/es
Publication of MX363826B publication Critical patent/MX363826B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24003—Microbial collagenase (3.4.24.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica a base de centella asiática (Hydrocotyle asiática L.) para el tratamiento de úlceras en miembros inferiores, caracterizada porque comprende de 10% a 18% en peso de centella asiática: de 67% a 75% en peso de acexamato de sodio; y de 10% a 18% en peso de un agente antibiótico.
MX2013004077A 2013-04-11 2013-04-11 Composicion farmaceutica a base de centella asiatica (hydrocotyle asiatica l.) para el tratamiento de ulceras en miembros inferiores. MX363826B (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MX2013004077A MX363826B (es) 2013-04-11 2013-04-11 Composicion farmaceutica a base de centella asiatica (hydrocotyle asiatica l.) para el tratamiento de ulceras en miembros inferiores.
PCT/IB2014/000510 WO2014167405A1 (en) 2013-04-11 2014-04-09 Treating lower limb ulcers with centella asiatica
US14/784,085 US10232004B2 (en) 2013-04-11 2014-04-09 Pharmaceutical composition based on Centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013004077A MX363826B (es) 2013-04-11 2013-04-11 Composicion farmaceutica a base de centella asiatica (hydrocotyle asiatica l.) para el tratamiento de ulceras en miembros inferiores.

Publications (2)

Publication Number Publication Date
MX2013004077A MX2013004077A (es) 2014-10-17
MX363826B true MX363826B (es) 2019-04-03

Family

ID=51689009

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004077A MX363826B (es) 2013-04-11 2013-04-11 Composicion farmaceutica a base de centella asiatica (hydrocotyle asiatica l.) para el tratamiento de ulceras en miembros inferiores.

Country Status (3)

Country Link
US (1) US10232004B2 (es)
MX (1) MX363826B (es)
WO (1) WO2014167405A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2668966C1 (ru) * 2018-01-25 2018-10-05 "Акционерное общество "Всесоюзный научный центр по безопасности биологически активных веществ" (АО "ВНЦ БАВ") Комплексные соли ацексамовой кислоты, стимулирующие регенерацию костной ткани, ускоряющие процессы репаративного остеогенеза, стимулирующие минерализацию костной ткани при остеопорозе
CN108524622A (zh) * 2018-07-10 2018-09-14 李�杰 一种杀灭阴道霉菌的卫生棉条

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459661A1 (fr) 1979-06-25 1981-01-16 Phybiocit Laboratoires Nouvelle composition medicamenteuse a base de plantes, et procede de preparation
US20020197336A1 (en) 2001-01-09 2002-12-26 Thomas Mini Wound healing antiscarring topical composition of centella and ginseng
DE20109044U1 (de) 2001-05-30 2001-08-09 Weber & Weber GmbH & Co. KG, 82266 Inning Pharmazeutische Zubereitung
AU2005229008B2 (en) 2004-03-23 2011-03-24 Lifeline Nutraceuticals Corporation Compositions and method for alleviating inflammation and oxidative stress in a mammal
US8858968B2 (en) * 2005-12-05 2014-10-14 L'oreal Use of tyrosine-arginine dipeptide and niacinamide as substance P antagonist
FR2902998B1 (fr) 2006-07-03 2012-09-21 Oreal Utilisation d'au moins un derive c-glycoside a titre d'agent apaisant
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
US8071139B2 (en) 2008-09-04 2011-12-06 Alan David Widgerow Treatment of damaged skin
FR2936706B1 (fr) * 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
FR2972110B1 (fr) 2011-03-01 2013-11-15 Oreal Procede de traitement cosmetique des rougeurs cutanees

Also Published As

Publication number Publication date
MX2013004077A (es) 2014-10-17
US10232004B2 (en) 2019-03-19
WO2014167405A1 (en) 2014-10-16
US20160074454A1 (en) 2016-03-17

Similar Documents

Publication Publication Date Title
CA2909335C (en) Fenfluramine for use in the treatment of dravet syndrome
PH12016500762A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
MX366481B (es) Deaza-purinonas macrociclicas para el tratamiento de infecciones virales.
NI201500118A (es) Imidazopiridazinas sustituidas
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
CL2012002326A1 (es) Uso de una combinación de por lo menos un agente quimioterapéutico y una cantidad efectiva de un anticuerpo anti-vegf (factor de crecimiento endotelial vascular), porque sirve para preparar un medicamento útil en el tratamiento de cáncer ovárico; y su kit para tratar el cáncer ovárico sin tratamiento anterior en una paciente humana.
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
WO2015058664A8 (zh) 淫羊藿苷元在制备预防或治疗血细胞减少药物中的用途
EP4378535A3 (en) Antibiotic formulations for lower back pain
PH12015501888A1 (en) Novel bacteriophage and antibacterial composition comprising the same
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
PH12017501300A1 (en) Novel iodophor composition and methods of use
EP2490700A4 (en) EXTERNAL SKIN CARE COMPOSITION COMPRISING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND USE THEREOF
UY35848A (es) Tienopirimidinas
DOP2016000007A (es) Pirazolpiridinas sustituidas
MY193312A (en) Topical formulation for promoting wound healing
BR112016007487A2 (pt) composições compreendendo citrulina e leucina e seu uso no tratamento de diabetes e de síndrome meta-bólica
PH12020550232A1 (en) Pesticide composition containing thidiazuron and polyglutamic acid
MX2016012559A (es) Composiciones de protector solar.
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
MX2016005092A (es) Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos.
BR112018014723A2 (pt) fantasmas bacterianos para o tratamento de câncer
MX363826B (es) Composicion farmaceutica a base de centella asiatica (hydrocotyle asiatica l.) para el tratamiento de ulceras en miembros inferiores.
WO2018094023A3 (en) Cyclic dipeptides and wound healing

Legal Events

Date Code Title Description
FG Grant or registration